货号:A276968
同义名:
异麦角甾苷
/ Isoverbascoside
Isoacteoside是从Pedicularis striata Pall.草本植物中分离提取的天然化合物,具有显著抑制高级糖基化终产物形成的作用,IC50值为4.6-25.7 μM,相较于氨基guanidine(IC50=1,056 μM)和槲皮素(IC50=28.4 μM)为阳性对照,且通过阻断TLR4二聚化展现抗炎作用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Isoacteoside is a natural compound isolated and purified from the herb of Pedicularis striata Pall. which exhibit significant inhibition of advanced glycation end product formation with IC50 values of 4.6-25.7 μM, compared with those of aminoguanidine (IC50=1,056 μM) and quercetin (IC50=28.4 μM) as positive controls, and exhibits anti-inflammatory effects through blocking TLR4 dimerization. |
| Concentration | Treated Time | Description | References | |
| Bone marrow-derived macrophages (BMDMs) | 20, 40, 80 μM | 24 hours | To evaluate the inhibitory effect of Isoacteoside on LPS-induced cytokine release, results showed that Isoacteoside significantly suppressed the secretion of TNF-α, IL-6, and IL-1β. | Br J Pharmacol. 2017 Sep;174(17):2880-2896 |
| HEK293T cells | 80 μM | 24 hours | To evaluate the effect of Isoacteoside on TLR4 dimerization, results showed that Isoacteoside significantly inhibited LPS-induced TLR4 dimerization. | Br J Pharmacol. 2017 Sep;174(17):2880-2896 |
| RAW264.7 macrophages | 20, 40, 80 μM | 24 hours | To evaluate the inhibitory effect of Isoacteoside on LPS-induced inflammatory responses, results showed that Isoacteoside significantly suppressed the expression of COX-2, iNOS, TNF-α, IL-6, and IL-1β. | Br J Pharmacol. 2017 Sep;174(17):2880-2896 |
| SH-SY5Y cells | 50 μg/mL | 24 hours | Protected SH-SY5Y cells against Aβ1-42-induced neural damage and restored cell viability | Int J Mol Sci. 2017 Apr 24;18(4):895 |
| Administration | Dosage | Frequency | Description | References | ||
| BALB/c nude mice | HCC xenograft model | Intraperitoneal injection | 30 mg/kg | Once daily for two weeks | The combination of Isoacteoside and sorafenib significantly inhibits tumor growth, showing better efficacy than sorafenib monotherapy. | Commun Biol. 2025 Feb 8;8(1):205 |
| BALB/c mice | Xylene-induced ear oedema model, LPS-induced endotoxic shock model, and LPS-induced endotoxaemia-associated acute kidney injury (AKI) model | Intraperitoneal injection | 100 mg·kg-1 (ear oedema and endotoxic shock models); 25, 50, 100 mg·kg-1 (AKI model) | Single dose (ear oedema and endotoxic shock models); single dose and observed for 132 hours (endotoxic shock model); single dose and samples collected after 12 hours (AKI model) | To evaluate the anti-inflammatory effects of Isoacteoside in vivo, results showed that Isoacteoside significantly inhibited xylene-induced ear oedema, LPS-induced endotoxic death, and protected against LPS-induced acute kidney injury. | Br J Pharmacol. 2017 Sep;174(17):2880-2896 |
| Sprague-Dawley rats | Aβ1-42-induced Alzheimer's disease model | Oral | 2.5, 5.0 mg/kg | Once daily for 14 days | Ameliorated cognitive deficits induced by Aβ1-42, reduced amyloid deposition, and restored central cholinergic and monoaminergic function | Int J Mol Sci. 2017 Apr 24;18(4):895 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.60mL 0.32mL 0.16mL |
8.01mL 1.60mL 0.80mL |
16.01mL 3.20mL 1.60mL |
|
| CAS号 | 61303-13-7 |
| 分子式 | C29H36O15 |
| 分子量 | 624.59 |
| SMILES Code | O=C(/C=C/C1=CC=C(O)C(O)=C1)OC[C@H]2O[C@@H](OCCC3=CC=C(O)C(O)=C3)[C@H](O)[C@H]([C@@H]2O)O[C@H](O[C@@H](C)[C@@H]4O)[C@@H]([C@@H]4O)O |
| MDL No. | MFCD06798947 |
| 别名 | 异麦角甾苷 ;Isoverbascoside |
| 运输 | 蓝冰 |
| InChI Key | FNMHEHXNBNCPCI-QEOJJFGVSA-N |
| Pubchem ID | 6476333 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 250 mg/mL(400.26 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1